FrancophonIA/ELRC3.0 huggingface dataset:
English: Due to the similarity between lamivudine and emtricitabine, a component of efavirenz/emtricitabine/tenofovir disoproxil, efavirenz/emtricitabine/tenofovir disoproxil should not be administered concomitantly with lamivudine (see section 4.4).
Swedish: På grund av likheter mellan lamivudin och emtricitabin, en komponent i efavirenz/emtricitabin/tenofovirdi soproxil, ska efavirenz/emtricitabin/tenofovirdi soproxil inte ges samtidigt med lamivudin (se avsnitt 4.4).
English: Close monitoring of immunosuppressant concentrations for at least two weeks (until stable concentrations are reached) is recommended when starting or stopping treatment with efavirenz/emtricitabine/tenofovir disoproxil.
Swedish: Noggrann övervakning av koncentrationerna hos det immunsuppressiva läkemedlet i minst två veckor (tills stabila koncentrationer uppås) rekommenderas när
English: Evening Cmin: ↑ 24% (↑ 3 to
Swedish: Kvälls-Cmin: ↑ 24 % (↑ 3 till ↑ 50)
English: Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan can reduce the amount of statins in your blood.
Swedish: Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan kan minska mängden statiner i blodet.
English: Recommendation concerning coadministration with efavirenz/emtricitabine/tenofovir disoproxil (efavirenz 600 mg, emtricitabine 200 mg, tenofovir disoproxil 245 mg)
Swedish: Rekommendationer angående samtidig administrering av efavirenz/emtricitabin/tenofovir disoproxi (efavirenz 600 mg, emtricitabin 200 mg, tenofovirdisoproxil 245 mg)
English: Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan may affect your kidneys.
Swedish: Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan kan påverka dina njurar.
English: Rosuvastatin/Emtricitabine
Swedish: Rosuvastatin/emtricitabin
English: Swallow Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan whole with water.
Swedish: Svälj Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan hel med vatten.
English: Ear and labyrinth disorders: Uncommon tinnitus, vertigo
Swedish: Öron och balansorgan: Ovanliga tinnitus, svindel
English: Mild-to-moderate rash has been reported with the individual components of efavirenz/emtricitabine/tenofovir disoproxil.
Swedish: Milda till måttliga hudutslag har rapporterats för de enskilda innehållsämnena i efavirenz/emtricitabin/tenofovirdisoproxil.
English: Nervous system symptoms associated with efavirenz usually begin during the first one or two days of therapy and generally resolve after the first two to four weeks.
Swedish: Centralnervösa symtom uppkommer vanligtvis under de första en eller två dagarnas behandling och upphör vanligtvis efter de första två till fyra veckorna.
English: Efavirenz/emtricitabine/tenofovir disoproxil is not recommended for patients with moderate or severe renal impairment (creatinine clearance < 50 ml/min).
Swedish: Efavirenz/emtricitabin/tenofovirdisoproxil rekommenderas inte för patienter med måttlig eller svårt nedsatt njurfunktion (kreatininclearance < 50 ml/min).
English: Fluoxetine/Emtricitabine
Swedish: Fluoxetin/emtricitabin
English: The pharmacokinetics of efavirenz/emtricitabine/tenofovir disoproxil have not been studied in HIV infected patients with hepatic impairment.
Swedish: Farmakokinetiken hos efavirenz/emtricitabin/tenofovirdisoproxil har inte studerats hos hiv-infekterade patienter med nedsatt leverfunktion.
English: CCR5 antagonist Maraviroc/Efavirenz (100 mg b.i.d./600 mg q.d.)
Swedish: CCR5-antagonist Maravirok/efavirenz (100 mg b.i.d./ 600 mg q.d.)
English: Where discontinuation of therapy with one of the components of Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan is indicated or where dose modification is necessary, separate preparations of efavirenz, emtricitabine and tenofovir disoproxil are available.
Swedish: Vid behov att avsluta behandling med någon av komponenterna i Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan eller då dosanpassning krävs, finns de enskilda komponenterna av efavirenz, emtricitabin och tenofovirdisoproxil tillgängliga.
English: Atovaquone and proguanil hydrochloride/Tenofovir disoproxil
Swedish: Atovakvon och proguanilhydroklorid/tenofovirdisopr oxil
English: AUC: ↓ 39% (↓ 27 to ↓ 50) Cmax: ↓ 29% (↓ 15 to ↓ 40) Cmin: ↓ 46% (↓ 31 to ↓ 58) Efavirenz:
Swedish: AUC: ↓ 39 % (↓ 27 till ↓ 50) Cmax: ↓ 29 % (↓ 15 till ↓ 40) Cmin: ↓ 46 % (↓ 31 till ↓ 58) Efavirenz:
English: Efavirenz/emtricitabine/tenofovir disoproxil has not been studied in patients over the age of 65.
Swedish: Efavirenz/emtricitabin/tenofovirdisoproxil har inte studerats hos patienter över 65 år.
English: Methadone/Emtricitabine
Swedish: Metadon/emtricitabin
English: Microcrystalline cellulose Silica, colloidal anhydrous Sodium metabisulfite Lactose monohydrate Iron oxide red (E172)
Swedish: Mikrokristallin cellulosa Kiseldioxid, kolloidal, vattenfri Natriummetabisulfit Laktosmonohydrat
English: AUC: ↓ 39% (↓ 21 to ↓ 53) Cmax: ↓ 37% (↓ 20 to ↓ 51) Cmin: ↓ 44% (↓ 27 to ↓ 58) (decrease in itraconazole concentrations: CYP3A4 induction)
Swedish: AUC: ↓ 39 % (↓ 21 till ↓ 53) Cmax: ↓ 37 % (↓ 20 till ↓ 51) Cmin: ↓ 44 % (↓ 27 till ↓ 58) (minskning av itrakonazolkoncentrationer: induktion av CYP3A4)
English: Norepinephrine and dopamine reuptake inhibitor Bupropion/Efavirenz [150 mg single dose (sustained release)/600 mg q.d.]
Swedish: Norepinefrin- och dopaminåterupptagshämmare Bupropion/efavirenz [150 mg enkeldos (fördröjd frisättning)/600 mg q.d.]
English: Bone effects
Swedish: Effektm ått
English: St. John's wort (Hypericum perforatum): Co-administration of efavirenz/emtricitabine/tenofovir disoproxil and St. John's wort or herbal preparations containing St. John's wort is contraindicated.
Swedish: Johannesört (Hypericum perforatum): Samtidig administrering med efavirenz/emtricitabin/tenofovirdisoproxil och växtbaserade läkemedel innehållande Johannesört är kontraindicerad.
English: Darunavir/ritonavir/Tenofovir disoproxil (300 mg b.i.d.
Swedish: Darunavir/ritonavir/tenofovirdisoprox il (300 mg b.i.d.
English: - any signs of skin rash.
Swedish: - symtom på hudutslag.
English: Lopinavir/ritonavir/Tenofovir disoproxil (400 mg b.i.d./100 mg b.i.d./245 mg q.d.)
Swedish: Lopinavir/ritonavir/tenofovirdisoprox il (400 mg b.i.d./ 100 mg b.i.d./ 245 mg q.d.)
English: The administration of efavirenz/emtricitabine/tenofovir disoproxil with food may increase efavirenz exposure (see section 5.2) and may lead to an increase in frequency of adverse reactions (see section 4.8).
Swedish: Administrering av efavirenz/emtricitabin/tenofovirdisoproxil med föda kan ge förhöjda koncentrationer av efavirenz (se avsnitt 5.2) och leda till en ökad biverkningsfrekvens (se avsnitt 4.8).
English: Indinavir/Tenofovir disoproxil (800 mg q8h/245 mg q.d.)
Swedish: Indinavir/tenofovirdisoproxil (800 mg q8h/245 mg q.d.)
English: Artemether/Lumefantrine/Tenofovir disoproxil
Swedish: Artemeter/lumefantrin/tenofovirdisop roxil
English: Patients receiving efavirenz/emtricitabine/tenofovir disoproxil or any other antiretroviral therapy may continue to develop opportunistic infections and other complications of HIV infection, and therefore should remain under close clinical observation by physicians experienced in the treatment of patients with HIV associated diseases.
Swedish: Patienter som får efavirenz/emtricitabin/tenofovirdisoproxil eller någon annan antiretroviral terapi kan fortsätta att utveckla opportunistiska infektioner och andra komplikationer från hiv-infektion.
English: Co-administration of ritonavir at doses of 600 mg and efavirenz/emtricitabine/tenofovir disoproxil is not recommended.
Swedish: Samtidig administrering av ritonavir med doser på 600 mg och efavirenz/emtricitabin/tenofovirdi soproxil rekommenderas inte.
English: Indinavir/Emtricitabine (800 mg q8h/200 mg q.d.)
Swedish: Indinavir/emtricitabin (800 mg q8h/200 mg q.d.)
English: Methadone/Tenofovir disoproxil (40-110 mg q.d./245 mg q.d.)
Swedish: Metadon/tenofovirdisoproxil (40-110 mg q.d./ 245 mg q.d.)
English: AUC: ↓ 71% (↓ 67 to ↓ 74) Cmax: ↓ 51% (↓ 46 to ↓ 56) Cmin: ↓ 91% (↓ 88 to ↓ 92) Efavirenz:
Swedish: AUC: ↓ 71 % (↓ 67 till ↓ 74) Cmax: ↓ 51 % (↓ 46 till ↓ 56) Cmin: ↓ 91 % (↓ 88 till ↓ 92)
English: AUC: ↑ 34% (↑ 18 to ↑ 53) Cmax: ↑ 49% (↑ 32 to ↑ 69) Efavirenz:
Swedish: AUC: ↑ 34 % (↑ 18 till ↑ 53) Cmax: ↑ 49 % (↑ 32 till ↑ 69)
English: Therefore coadministration of atazanavir/ritonavir and efavirenz/emtricitabine/tenofovir disoproxil is not recommended (see Table 1).
Swedish: Därmed kan inte samtidig administrering av atanzavir/ritonavir och efavirenz/emtricitabin/tenofovirdisoproxil rekommenderas (se tabell 1).
English: AUC: ↓ 36% (↓ 32 to ↓ 40) Cmax: ↓ 21% (↓ 15 to ↓ 26) Cmin: ↓ 47% (↓ 41 to ↓ 53) (decrease in carbamazepine concentrations: CYP3A4 induction; decrease in efavirenz concentrations: CYP3A4 and CYP2B6 induction) Co-administration of higher doses of either efavirenz or
Swedish: AUC: ↓ 36 % (↓ 32 till ↓ 40) Cmax: ↓ 21 % (↓ 15 till ↓ 26) Cmin: ↓ 47 % (↓ 41 till ↓ 53) (minskning av karbamazepinkoncentrationer: (induktion av CYP3A4; minskning av efavirenzkoncentrationer: induktion av CYP3A4 och CYP2B6)
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains 600 mg of efavirenz, 200 mg of emtricitabine and 245 mg of tenofovir disoproxil (as maleate).
Swedish: DEKLARATION AV AKTIV SUBSTANS En filmdragerad tablett innehåller 600 mg efavirenz, 200 mg emtricitabin och 245 mg tenofovirdisoproxil (som maleat).
English: - if you are currently taking any of the following medicines (see also “Other Medicines and Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan”): - astemizole or terfenadine (used to treat hay fever or other allergies) - bepridil (used to treat heart disease) - cisapride (used to treat heartburn) - elbasvir/grazoprevir (used to treat hepatitis C) - ergot alkaloids (for example, ergotamine, dihydroergotamine, ergonovine, and methylergonovine) (used to treat migraines and cluster headaches) - midazolam or triazolam (used to help you sleep) - pimozide, imipramine, amitriptyline or clomipramine (used to treat certain mental conditions) - St. John's wort (Hypericum perforatum) (a herbal preparation used for depression and anxiety) - voriconazole (used to treat fungal infections) - flecainide, metoprolol (used to treat irregular heart beat) - certain antibiotics (macrolides, fluoroquinolones, imidazole) - triazole antifungal agents - certain antimalarial agents - methadone (used to treat opiate addiction)
Swedish: - Om du samtidigt tar något av följande läkemedel (se även ”Andra läkemedel och Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan”): - astemizol eller terfenadin (används för att behandla hösnuva eller andra allergier) - bepridil (används för att behandla hjärtsjukdomar) - cisaprid (används för att behandla halsbränna) - elbasvir/grazoprevir (används för att behandla hepatit C) - ergotalkaloider (t ex ergotamin, dihydroergotamin, ergonovin och metylergonovin)
English: Simvastatin/Emtricitabine
Swedish: Simvastatin/emtricitabin
English: INFORMATION IN BRAILLE Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan
Swedish: INFORMATION I PUNKTSKRIFT Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan
English: Rifabutin/Emtricitabine
Swedish: Rifabutin/emtricitabin
English: Ethinyloestradiol/Tenofovir disoproxil (-/245 mg q.d.)
Swedish: Etinylöstradiol/tenofovirdisoproxil (−/245 mg q.d.)
English: Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan can reduce the amount of the anticonvulsant in your blood.
Swedish: Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan kan minska mängden antiepileptikum i blodet.
English: The administration of efavirenz/emtricitabine/tenofovir disoproxil with food may increase efavirenz exposure and may lead to an increase in the frequency of adverse reactions (see sections 4.4 and 5.2).
Swedish: Administrering av efavirenz/emtricitabin/tenofovirdisoproxil med föda kan ge förhöjda koncentrationer av efavirenz och leda till en ökad biverkningsfrekvens (se avsnitt 4.4 och 5.2).
English: Patients must not have experienced virological failure on any prior antiretroviral therapy and must be known not to have harboured virus strains with mutations conferring significant resistance to any of the three components contained in Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan prior to initiation of their first antiretroviral treatment regimen (see sections 4.4 and 5.1).
Swedish: Det ska även vara känt att det inte förekom virus med signifikant resistens mot någon av de i Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan tre ingående innehållsämnen före påbörjande av den första antiretrovirala behandlingen (se avsnitt 4.4 och
English: AUC: ↓ 53% (↓ 61 to ↓ 43) Cmax: ↓ 47% (↓ 57 to ↓ 36) Cmin: ↓ 57% (↓ 64 to ↓ 48) Efavirenz:
Swedish: AUC: ↓ 53 % (↓ 61 till ↓ 43) Cmax: ↓ 47 % (↓ 57 till ↓ 36) Cmin: ↓ 57 % (↓ 64 till ↓ 48)
English: Simeprevir/Tenofovir disoproxil (150 mg q.d./245 mg q.d.)
Swedish: Simeprevir/tenofovirdisoproxil (150 mg q.d./ 245 mg q.d.)
English: Lopinavir/ritonavir/Emtricitabine
Swedish: Lopinavir/ritonavir/emtricitabin
English: Posaconazole/Emtricitabine
Swedish: Posakonazol/emtricitabin
English: Bupropion/Emtricitabine
Swedish: Bupropion/emtricitabin
English: Each Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan film-coated tablet contains 600 mg of efavirenz, 200 mg of emtricitabine and 245 mg of tenofovir disoproxil (as maleate).
Swedish: En filmdragerad tablett Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan innehåller 600 mg efavirenz, 200 mg emtricitabin och 245 mg tenofovirdisoproxil (som maleat).
English: AUC: ↓ 13% Cmin: ↓ 31% Cmax: ↓ 15% (CYP3A4 induction) Efavirenz:
Swedish: AUC: ↓ 13 % Cmin: ↓ 31 % Cmax: ↓ 15 % (induktion av CYP3A4)
English: AUC: ↓ 34% (↓ 41 to ↓ 25) Cmax: ↓ 34% (↓ 41 to ↑ 25) Cmin: ↓ 34% (↓ 43 to ↑ 24) Sofosbuvir:
Swedish: AUC: ↓ 34 % (↓ 41 till ↓ 25) Cmax: ↓ 34 % (↓ 41 till ↑ 25) Cmin: ↓ 34 % (↓ 43 till ↑ 24)
English: LIPID LOWERING MEDICINAL PRODUCTS HMG Co-A Reductase Inhibitors
Swedish: Totalt aktiva HMG Co-A reduktashämmare:
English: Methadone/Efavirenz (35-100 mg q.d./600 mg q.d.)
Swedish: Metadon/efavirenz (35-100 mg q.d./ 600 mg q.d.)
English: Atazanavir/ritonavir/Efavirenz (400 mg q.d./200 mg q.d./600 mg q.d., all administered with food)
Swedish: Atazanavir/ritonavir/efavirenz (400 mg q.d./ 200 mg q.d./ 600 mg q.d., samtliga administreras med mat)
English: AUC: ↑ 22% Cmin: ↑ 37%
Swedish: Cmin: ↑ 37 %
English: • angry behaviour, suicidal thoughts, strange thoughts, paranoia, unable to think clearly, mood being affected, seeing or hearing things that are not really there (hallucinations), suicide attempts, personality change (psychosis), catatonia (a condition in which the patient is rendered motionless and speechless for a period)
Swedish: • argsint uppträdande, självmordstankar, konstiga tankar, paranoia, oförmögen att tänka klart,
English: AUC: ↔*/** (↓ 10% to ↑ 26%) Cmax: ↔*/** (↓ 5% to ↑ 26%) Cmin: ↑ 12%*/** (↓ 16 to ↑ 49) (CYP3A4 induction).
Swedish: Cmax: ↔*/ ** (↓ 5 % till ↑ 26 %) Cmin: ↑ 12 %*/** (↓ 16 till ↑ 49) (induktion av CYP3A4) * Vid jämförelse med atazanavir 300 mg/ritonavir 100 mg q.d.
English: Where discontinuation of therapy with one of the components of efavirenz/emtricitabine/tenofovir disoproxil is indicated or where dose modification is necessary, separate preparations of efavirenz, emtricitabine and tenofovir disoproxil are available.
Swedish: Då det indikeras att behandlingen med ett av innehållsämnena i efavirenz/emtricitabin/tenofovirdisoproxil bör avbrytas eller då dosjusteringar krävs, finns de enskilda innehållsämnena efavirenz, emtricitabin och tenofovirdisoproxil tillgängliga.
English: Etonogestrel/Tenofovir disoproxil
Swedish: Etonogestrel/tenofovirdisoproxil
English: Ritonavir/Emtricitabine
Swedish: Ritonavir/emtricitabin
English: C.
Swedish: CI)
English: Atorvastatin/Emtricitabine
Swedish: Atorvastatin/emtricitabin
English: Rifampicin/Emtricitabine
Swedish: Rifampicin/emtricitabin
English: Selective Serotonin Reuptake Inhibitors (SSRIs) Sertraline/Efavirenz (50 mg q.d./600 mg q.d.)
Swedish: ANTIDEPRESSIVA MEDEL Selektiva serotoninåterupptagshämmare (SSRI-preparat) Sertralin/efavirenz (50 mg q.d./ 600 mg q.d.)
English: As a fixed combination, efavirenz/emtricitabine/tenofovir disoproxil should not be administered concomitantly with other medicinal products containing the components, emtricitabine or tenofovir disoproxil.
Swedish: Som en fast doskombination ska inte efavirenz/emtricitabin/tenofovirdisoproxil ges samtidigt med andra läkemedel innehållande de ingående komponenterna emtricitabin eller tenofovirdisoproxil.
English: Itraconazole/Emtricitabine
Swedish: Itrakonazol/emtricitabin
English: AUC: ↓ 10% C12h: ↓ 13%
Swedish: AUC: ↓ 10 % C12h: ↓ 13 % Cmax: ↓ 23 %
English: Clarithromycin/Emtricitabine
Swedish: Klaritromycin/emtricitabin
English: It is recommended that Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan be taken on an empty stomach since food may increase efavirenz exposure and may lead to an increase in the frequency of adverse reactions (see sections 4.4 and 4.8).
Swedish: Det rekommenderas att Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan tas på fastande mage då föda kan ge förhöjda koncentrationer av efavirenz och leda till en ökad biverkningsfrekvens (se avsnitt 4.4 och 4.8).
English: Efavirenz/emtricitabine/tenofovir disoproxil has not been evaluated in the presence of food.
Swedish: Efavirenz/emtricitabin/tenofovirdisoproxil har inte utvärderats tillsammans med föda.
English: Diltiazem/Tenofovir disoproxil
Swedish: Diltiazem/tenofovirdisoproxil
English: The pharmacokinetics of efavirenz/emtricitabine/tenofovir disoproxil have not been studied in patients with hepatic impairment.
Swedish: Farmakokinetiken hos efavirenz/emtricitabin/tenofovirdisoproxil har inte studerats hos patienter med nedsatt leverfunktion.
English: Clarithromycin/Tenofovir disoproxil
Swedish: Klaritromycin/tenofovirdisoproxil
English: AUC: ↓ 69% (↓ 62 to ↓ 73) Cmax: ↓ 76% (↓ 63 to ↓ 79) Simvastatin acid:
Swedish: AUC: ↓ 69 % (↓ 62 till ↓ 73) Cmax: ↓ 76 % (↓ 63 till ↓ 79)
English: No data are currently available from clinical studies with efavirenz/emtricitabine/tenofovir disoproxil in treatment-naïve patients or in heavily pretreated patients.
Swedish: För närvarande saknas data från studier med efavirenz/emtricitabin/tenofovirdisoproxil på tidigare obehandlade patienter eller på tungt förbehandlade patienter.
English: Atazanavir/ritonavir/Efavirenz (400 mg q.d./100 mg q.d./600 mg q.d., all administered with food)
Swedish: Atazanavir/ritonavir/efavirenz (400 mg q.d./ 100 mg q.d./ 600 mg q.d., samtliga administreras med mat)
English: AUC: ↓ 83% (↓ 79 to ↓ 87) Cmax: ↓ 80% (↓ 77 to ↓ 83) Cmin: ↓ 86% (↓ 80 to ↓ 90) (induction of metabolism) Efavirenz: no clinically significant interaction.
Swedish: Levonorgestrel (aktiv metabolit): AUC: ↓ 83 % (↓ 79 till ↓ 87) Cmax: ↓ 80 % (↓ 77 till ↓ 83) Cmin: ↓ 86 % (↓ 80 till ↓ 90) (induktion av metabolism)
English: Paroxetine/Emtricitabine
Swedish: Paroxetin/emtricitabin
English: Dose adjustment of buprenorphine may not be necessary when coadministered with efavirenz/emtricitabine/tenofovir disoproxil.
Swedish: Dosjustering av buprenorfin kanske inte behövs vid administrering i kombination med efavirenz/emtricitabin/tenofovirdi soproxil.
English: Rifampicin/Tenofovir disoproxil (600 mg q.d./245 mg q.d.)
Swedish: Rifampicin/tenofovirdisoproxil (600 mg q.d./ 245 mg q.d.)
English: Co-administration of simeprevir with efavirenz/emtricitabine/tenofovir disoproxil is not recommended.
Swedish: Samtidig administrering av simeprevir med efavirenz/emtricitabin/tenofovirdi soproxil rekommenderas inte.
English: For co-administration of efavirenz with low-dose ritonavir in combination with a protease inhibitor, see section on ritonavir below.
Swedish: Se avsnittet om ritonavir ovan för samtidig administrering av efavirenz med lågdos ritonavir och en proteashämmare.
English: AUC: ↓ 75% (↓ 62 to ↓ 84) Cmax: ↓ 44% (↓ 20 to ↓ 61) Proguanil:
Swedish: AUC: ↓ 75 % (↓ 62 till ↓ 84) Cmax: ↓ 44 % (↓ 20 till ↓ 61)
English: Carbamazepine/Emtricitabine
Swedish: Karbamazepin/emtricitabin
English: Clarithromycin/Efavirenz (500 mg b.i.d./400 mg q.d.)
Swedish: Klaritromycin/efavirenz (500 mg b.i.d./ 400 mg q.d.)
English: Patients with moderate or severe renal impairment require dose interval adjustment of emtricitabine and tenofovir disoproxil that cannot be achieved with the combination tablet (see sections 4.2 and 4.4).
Swedish: Patienter med måttlig eller svårt nedsatt njurfunktion behöver justering av dosintervallet av emtricitabin och tenofovirdisoproxil vilket inte kan göras med kombinationstabletten (se avsnitt 4.2 och 4.4).
English: Sertraline/Tenofovir disoproxil
Swedish: Sertralin/tenofovirdisoproxil
English: Maraviroc/Emtricitabine
Swedish: Maravirok/emtricitabin
English: Lopinavir/ritonavir tablets/Efavirenz (400/100 mg b.i.d./600 mg q.d.)
Swedish: Lopinavir/ritonavir-tabletter/efavirenz (400/100 mg b.i.d./ 600 mg q.d.)
English: Cmax: ↔ C24h: ↔
Swedish: Emtricitabin: AUC: ↔ Cmax: ↔ C24h: ↔
English: Dose adjustments of diltiazem when co-administered with efavirenz/emtricitabine/tenofovir disoproxil should be guided by clinical response (refer to the Summary of Product Characteristics for diltiazem).
Swedish: Dosjusteringar av diltiazem vid samtidig administrering av efavirenz/emtricitabin/tenofovirdi soproxil bör anpassas efter kliniskt svar (se Produktresumé för diltiazem).
English: If you forget to take Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan
Swedish: Om du har glömt att ta Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan
English: Do not breast-feed during treatment with Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan.
Swedish: Amma inte under behandling med Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan.
English: Efavirenz/emtricitabine/tenofovir disoproxil is recommended for administration on an empty stomach since food may increase efavirenz exposure and may lead to an increase in the frequency of adverse reactions (see sections 4.4 and 4.8).
Swedish: Efavirenz/emtricitabin/tenofovirdisoproxil rekommenderas att tas på fastande mage eftersom föda kan öka koncentrationen av efavirenz och leda till en ökad biverkningsfrekvens (se avsnitt 4.4 och 4.8).
English: AUC: ↓ 38% (↓ 28 to ↓ 47) Cmax: ↓ 32% (↓ 15 to ↓ 46) Cmin: ↓ 45% (↓ 31 to ↓ 56) Efavirenz:
Swedish: AUC: ↓ 38 % (↓ 28 till ↓ 47) Cmax: ↓ 32 % (↓ 15 till ↓ 46) Cmin: ↓ 45 % (↓ 31 till ↓ 56)
English: Seizures
Swedish: hudutslag
English: If you stop taking Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan
Swedish: Om du slutar att ta Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan
English: • increased appetite
Swedish: • aptitökning
English: Efavirenz/emtricitabine/tenofovir disoproxil and vigabatrin or gabapentin can be co-administered without dose adjustment.
Swedish: Efavirenz/emtricitabin/tenofovirdi soproxil och vigabatrin eller gabapentin kan administreras samtidigt utan någon dosjustering.
English: Voriconazole/Emtricitabine
Swedish: Vorikonazol/emtricitabin
English: Antimycobacterials Rifabutin/Efavirenz (300 mg q.d./600 mg q.d.)
Swedish: Medel mot mykobakterier Rifabutin/efavirenz (300 mg q.d./ 600 mg q.d.)
English: AUC: ↓ 27% (↓ 20 to ↓ 33) Cmax: ↓ 20% (↓ 15 to ↓ 24) Cmin: ↓ 35% (↓ 24 to ↓ 44) Efavirenz:
Swedish: AUC: ↓ 27 % (↓ 20 till ↓ 33) Cmax: ↓ 20 % (↓ 15 till ↓ 24) Cmin: ↓ 35 % (↓ 24 till ↓ 44)
English: CARDIOVASCULAR AGENTS Calcium Channel Blockers Diltiazem/Efavirenz (240 mg q.d./600 mg q.d.)
Swedish: KARDIOVASKULÄRA LÄKEMEDEL Kalciumantagonister Diltiazem/efavirenz (240 mg q.d./ 600 mg q.d.)
English: Cmax: ↓ 23% (↓ 30 to ↑ 16) Efavirenz:
Swedish: Cmax: ↓ 23 % (↓ 30 to ↑ 16)
English: AUC: ↓ 69% (↓ 55 to ↓ 79) Cmax: ↓ 60% (↓ 50 to ↓ 68) Cmin: ↓ 63% (↓ 44 to ↓ 75) Desacetyl diltiazem:
Swedish: AUC: ↓ 69 % (↓ 55 till ↓ 79) Cmax: ↓ 60 % (↓ 50 till ↓ 68) Cmin: ↓ 63 % (↓ 44 till ↓ 75)
English: Didanosine/Emtricitabine
Swedish: Didanosin/emtricitabin
English: Dose adjustments of calcium channel blockers when co-administered with efavirenz/emtricitabine/tenofovir disoproxil should be guided by clinical response (refer to the Summary of Product Characteristics for the calcium channel blocker).
Swedish: Dosjusteringar av kalciumantagonister vid samtidig administrering av efavirenz/emtricitabin/tenofovirdi soproxil bör anpassas efter kliniskt svar (se Produktresumé för kalciumantagonisten).